ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,861Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 247

$765K Total Retail Price of All Prescriptions

Rank: 7 out of 247

549 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 549 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 549 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 7,702 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 434 328 1 1
AMLODIPINE BESYLATE 381 355 2 6
LISINOPRIL 376 309 3 2
OMEPRAZOLE 326 278 4 4
ATORVASTATIN CALCIUM 298 272 5 8
LEVOTHYROXINE SODIUM 277 209 6 3
HYDROCHLOROTHIAZIDE 254 240 7 9
HYDROCODONE-ACETAMINOPHEN 230 138 S3 8 11
METOPROLOL TARTRATE 208 188 9 7
METFORMIN HCL 188 139 10 12
CRESTOR 161 126 11 30
FUROSEMIDE 157 135 12 5
ATENOLOL 151 134 13 10
DIOVAN 143 131 14 38
CITALOPRAM HBR 128 85 15 20
LOSARTAN POTASSIUM 125 118 16 15
GABAPENTIN 123 37 17 17
TRAZODONE HCL 115 110 18 28
LIPITOR 114 101 19 50
PROAIR HFA 107 63 20 29
SPIRIVA 106 105 21 26
ADVAIR DISKUS 106 99 21 18
METOPROLOL SUCCINATE 105 93 23 14
WARFARIN SODIUM 100 80 24 13
ALLOPURINOL 98 69 25 33
CARVEDILOL 97 96 26 59
TAMSULOSIN HCL 95 77 27 31
PREDNISONE 95 80 27 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 79 29 51
FLUOXETINE HCL 88 71 30 49
ALENDRONATE SODIUM 78 64 31 32
SERTRALINE HCL 70 65 32 16
CYMBALTA 64 55 33 52
PANTOPRAZOLE SODIUM 64 47 33 19
GLIPIZIDE 62 62 35 43
PEN NEEDLE 61 60 36 79
LEVEMIR FLEXPEN 60 53 37 164
ZOLPIDEM TARTRATE 60 46 37 24
VENLAFAXINE HCL ER 58 36 39 64
DONEPEZIL HCL 58 58 39 35
OXYCODONE HCL 56 17 S2 41 27
FLUTICASONE PROPIONATE 55 44 42 37
NAMENDA 54 54 43 47
PRAVASTATIN SODIUM 53 53 44 23
GLIMEPIRIDE 51 43 45 80
MORPHINE SULFATE ER 50 19 S2 46 125
JANUVIA 50 50 46 56
GLIPIZIDE XL 50 36 46 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.